Related Experiment Video

Updated: Jun 16, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

The efficacy of montelukast monotherapy in moderate persistent asthmatic children

Mahir Igde, Fehim Yasar Anlar

    Iranian Journal of Allergy, Asthma, and Immunology
    |February 4, 2010
    PubMed

    Insights

    Single montelukast treatment effectively manages moderate persistent asthma in children. This finding supports its use as a standalone therapy for pediatric moderate persistent asthma, offering a viable alternative to combination treatments.

    Area of Science:

    • Pediatric Pulmonology
    • Asthma Management
    • Pharmacotherapy

    Background:

    • Current asthma guidelines recommend leukotriene receptor antagonists for mild persistent asthma.
    • Uncertainty exists regarding their efficacy in moderate persistent asthma.
    • This study evaluates montelukast monotherapy in pediatric moderate persistent asthma.

    Discussion:

    • Both montelukast monotherapy and budesonide-montelukast combination therapy were effective in managing moderate persistent asthma in children.
    • Both treatment regimens were well-tolerated.
    • Montelukast monotherapy demonstrated comparable efficacy to combination therapy.

    Key Insights:

    • Sole montelukast treatment is an effective therapeutic option for children with moderate persistent asthma.
    • Montelukast monotherapy provides a well-tolerated and effective approach to pediatric asthma control.
    • The study provides evidence supporting the use of montelukast as a single agent in moderate persistent asthma.

    Outlook:

    • Further research could explore long-term outcomes of montelukast monotherapy.
    • Investigating patient adherence and quality of life could provide additional insights.
    • Comparative studies with other monotherapies may further refine treatment guidelines.

    Related Concept Videos

    Antiasthma Drugs: Leukotriene Modifiers01:19

    Antiasthma Drugs: Leukotriene Modifiers

    Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
    Leukotriene modifiers work through two distinct mechanisms:
    Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

    Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

    Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
    Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
    Asthma III: Clinical Manifestations01:13

    Asthma III: Clinical Manifestations

    Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
    Asthma: Pathogenesis and Management01:20

    Asthma: Pathogenesis and Management

    Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
    Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
    Asthma-IV: Diagnostic and Management01:30

    Asthma-IV: Diagnostic and Management

    The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
    Clinical Assessment for Asthma:
    This is the first step in diagnosing and managing asthma. It includes:
    Asthma-III: Symptoms and Complications01:24

    Asthma-III: Symptoms and Complications

    Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
    Classification of Asthma